Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to -$21.1 million.

  • Tandem Diabetes Care's Net Income towards Common Stockholders rose 906.63% to -$21.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$203.4 million, marking a year-over-year decrease of 6039.75%. This contributed to the annual value of -$96.0 million for FY2024, which is 5686.42% up from last year.
  • Latest data reveals that Tandem Diabetes Care reported Net Income towards Common Stockholders of -$21.1 million as of Q3 2025, which was up 906.63% from -$52.4 million recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Net Income towards Common Stockholders registered a high of $10.8 million during Q4 2021, and its lowest value of -$130.6 million during Q1 2025.
  • Over the past 5 years, Tandem Diabetes Care's median Net Income towards Common Stockholders value was -$23.3 million (recorded in 2024), while the average stood at -$31.7 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first surged by 16089.63% in 2021, then crashed by 95194.85% in 2022.
  • Over the past 5 years, Tandem Diabetes Care's Net Income towards Common Stockholders (Quarter) stood at $10.8 million in 2021, then plummeted by 247.28% to -$15.9 million in 2022, then crashed by 89.03% to -$30.0 million in 2023, then soared by 102.59% to $775000.0 in 2024, then tumbled by 2828.13% to -$21.1 million in 2025.
  • Its Net Income towards Common Stockholders was -$21.1 million in Q3 2025, compared to -$52.4 million in Q2 2025 and -$130.6 million in Q1 2025.